Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Historical Holders from Q4 2018 to Q1 2025

Symbol
ETON on Nasdaq
CUSIP
29772L108
Type / Class
Equity / Common Stock
Shares outstanding
25.7M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
13.1M
Holdings value
$175M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
71
Number of buys
51
Number of sells
-14
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EcoR1 Capital, LLC 7.7% $25.7M 1.98M EcoR1 Capital, LLC Dec 31, 2024

Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 16.7K $217K $12.98 1
2024 Q4 13.1M $175M +$42.3M $13.32 71
2024 Q3 9.51M $57M +$8.31M $6.00 48
2024 Q2 8.23M $27.1M +$3.4M $3.29 44
2024 Q1 7.18M $26.9M -$87.3K $3.75 43
2023 Q4 7.16M $31.4M +$1.22M $4.38 55
2023 Q3 6.9M $28.8M +$3.93M $4.17 50
2023 Q2 5.98M $20.9M +$440K $3.49 33
2023 Q1 5.84M $22.5M +$148K $3.85 34
2022 Q4 5.94M $16.7M -$1.03M $2.82 31
2022 Q3 6.05M $12.7M +$550K $2.10 28
2022 Q2 5.27M $13.8M -$20.2K $2.62 25
2022 Q1 5.48M $23.9M +$177K $4.36 27
2021 Q4 5.43M $23.3M -$881K $4.29 28
2021 Q3 5.96M $32.6M -$4.92M $5.04 36
2021 Q2 6.84M $51.8M -$13M $6.16 43
2021 Q1 8.79M $68M +$241K $7.32 49
2020 Q4 8.73M $70.9M +$13.6M $8.13 45
2020 Q3 6.46M $51M +$511K $7.90 34
2020 Q2 6.8M $37.1M +$4.61M $5.45 40
2020 Q1 5.97M $24.5M +$13.6M $4.10 17
2019 Q4 2.62M $18.9M +$2.67M $7.20 13
2019 Q3 2.28M $14.4M +$3.21M $6.32 13
2019 Q2 1.77M $14M +$2.1M $7.90 10
2019 Q1 1.5M $12M +$2.82M $8.00 12
2018 Q4 1.15M $7.05M +$7.05M $6.12 11